NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics that promotes nerve repair and regeneration in the treatment of cerebral stroke and spinal cord injury by targeting Nogo-A. Nogo-A is the most potent inhibitor of nerve fiber regeneration.

Location

Wagistrasse 27, 8952 Schlieren, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2015

  • Number of employees in Switzerland

    1-9

Key business